| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 1935 | 2003 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Møller, ... Archives of internal medicine 166 (15), 1632-1641, 2006 | 1308 | 2006 |
| Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk, AA Monforte, ... Aids 17 (8), 1179-1193, 2003 | 1221 | 2003 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1004 | 2008 |
| Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients A Alberti, N Clumeck, S Collins, W Gerlich, J Lundgren, G Palu, P Reiss, ... Journal of hepatology 42 (5), 615-624, 2005 | 493 | 2005 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 369 | 2011 |
| Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment Y Levy, C Lacabaratz, L Weiss, JP Viard, C Goujard, JD Lelièvre, F Boué, ... The Journal of clinical investigation 119 (4), 997-1007, 2009 | 367 | 2009 |
| The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D: A: D Study MG Law, N Friis‐Møller, WM El‐Sadr, R Weber, P Reiss, ... HIV medicine 7 (4), 218-230, 2006 | 349 | 2006 |
| Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis JZ Li, R Paredes, HJ Ribaudo, ES Svarovskaia, KJ Metzner, MJ Kozal, ... Jama 305 (13), 1327-1335, 2011 | 341 | 2011 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 338 | 2010 |
| Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination D Furman, BP Hejblum, N Simon, V Jojic, CL Dekker, R Thiébaut, ... Proceedings of the National Academy of Sciences 111 (2), 869-874, 2014 | 308 | 2014 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 294 | 2001 |
| Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis E Arrivé, ML Newell, DK Ekouevi, ML Chaix, R Thiebaut, B Masquelier, ... International journal of epidemiology 36 (5), 1009-1021, 2007 | 279 | 2007 |
| Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy B Marin, R Thiébaut, HC Bucher, V Rondeau, D Costagliola, M Dorrucci, ... AIDS (London, England) 23 (13), 1743, 2009 | 274 | 2009 |
| Reduced bone mineral density in HIV-infected patients: prevalence and associated factors C Cazanave, M Dupon, V Lavignolle-Aurillac, N Barthe, S Lawson-Ayayi, ... Aids 22 (3), 395-402, 2008 | 269 | 2008 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 251 | 2005 |
| Effectiveness of disease-management programs for improving diabetes care: a meta-analysis C Pimouguet, M Le Goff, R Thiébaut, JF Dartigues, C Helmer Cmaj 183 (2), E115-E127, 2011 | 233 | 2011 |
| Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999 R Thiébaut, V Daucourt, P Mercié, DK Ekouévi, D Malvya, P Morlat, ... Clinical Infectious Diseases 31 (6), 1482-1487, 2000 | 218 | 2000 |
| Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need … S Lodi, A Phillips, G Touloumi, R Geskus, L Meyer, R Thiébaut, ... Clinical infectious diseases 53 (8), 817-825, 2011 | 185 | 2011 |
| Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized … Y Levy, I Sereti, G Tambussi, JP Routy, JD Lelievre, JF Delfraissy, ... Clinical infectious diseases 55 (2), 291-300, 2012 | 176 | 2012 |
